G Cecener, G Guney Eskiler, U Egeli, B Tunca, A Alemdar, S Gokgoz, I Tasdelen. Mol Biol Rep 2016
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Unal Egeli, Gulsah Cecener, Berrin Tunca, Ismet Tasdelen. Cancer Invest 2006
Unal Egeli, Gulsah Cecener, Berrin Tunca, Ismet Tasdelen. Cancer Invest 2006
50
BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
H Yazici, O Bitisik, E Akisik, N Cabioglu, P Saip, M Muslumanoglu, G Glendon, E Bengisu, S Ozbilen, M Dincer,[...]. Br J Cancer 2000
H Yazici, O Bitisik, E Akisik, N Cabioglu, P Saip, M Muslumanoglu, G Glendon, E Bengisu, S Ozbilen, M Dincer,[...]. Br J Cancer 2000
50
Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients.
H Ozdag, M Tez, I Sayek, M Müslümanoglu, O Tarcan, F Içli, M Oztürk, T Ozçelik. Eur J Cancer 2000
H Ozdag, M Tez, I Sayek, M Müslümanoglu, O Tarcan, F Içli, M Oztürk, T Ozçelik. Eur J Cancer 2000
50
Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients.
Esra Manguoğlu, Sefik Güran, Deniz Yamaç, Taner Colak, Mehmet Simşek, Mehmet Baykara, Mustafa Akaydın, Güven Lüleci. Cancer Genet Cytogenet 2010
Esra Manguoğlu, Sefik Güran, Deniz Yamaç, Taner Colak, Mehmet Simşek, Mehmet Baykara, Mustafa Akaydın, Güven Lüleci. Cancer Genet Cytogenet 2010
50
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Fatemeh Karami, Parvin Mehdipour. Biomed Res Int 2013
Fatemeh Karami, Parvin Mehdipour. Biomed Res Int 2013
50
Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
A Esra Manguoglu, Güven Lüleci, Tayfun Ozçelik, Taner Colak, Hagit Schayek, Mustafa Akaydin, Eitan Friedman. Hum Mutat 2003
A Esra Manguoglu, Güven Lüleci, Tayfun Ozçelik, Taner Colak, Hagit Schayek, Mustafa Akaydin, Eitan Friedman. Hum Mutat 2003
50
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
50
BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.
Gulsah Cecener, Unal Egeli, Berrin Tunca, Elif Erturk, Secil Ak, Sehsuvar Gokgoz, Ismet Tasdelen, Gulcin Tezcan, Elif Demirdogen, Nuran Bayram,[...]. Cancer Invest 2014
Gulsah Cecener, Unal Egeli, Berrin Tunca, Elif Erturk, Secil Ak, Sehsuvar Gokgoz, Ismet Tasdelen, Gulcin Tezcan, Elif Demirdogen, Nuran Bayram,[...]. Cancer Invest 2014
50
Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer.
A Balci, P Huusko, K Pääkkönen, V Launonen, A Uner, A Ekmekçi, R Winqvist. Eur J Cancer 1999
A Balci, P Huusko, K Pääkkönen, V Launonen, A Uner, A Ekmekçi, R Winqvist. Eur J Cancer 1999
50
Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Sefik Güran, Ahmet Ozet, Murat Dede, Johan J P Gille, Müfit Cemal Yenen. Cancer Genet Cytogenet 2005
Sefik Güran, Ahmet Ozet, Murat Dede, Johan J P Gille, Müfit Cemal Yenen. Cancer Genet Cytogenet 2005
50
Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients.
Gulsah Cecener, Leila Sabour Takanlou, Maryam Sabour Takanlou, Unal Egeli, Gamze Guney Eskiler, Secil Aksoy, Ufuk Unal, Havva Tezcan, Isil Ezgi Eryilmaz, Mustafa Sehsuvar Gokgoz,[...]. Cancer Genet 2020
Gulsah Cecener, Leila Sabour Takanlou, Maryam Sabour Takanlou, Unal Egeli, Gamze Guney Eskiler, Secil Aksoy, Ufuk Unal, Havva Tezcan, Isil Ezgi Eryilmaz, Mustafa Sehsuvar Gokgoz,[...]. Cancer Genet 2020
50
Triple positive breast cancer: a distinct subtype?
Patrizia Vici, Laura Pizzuti, Clara Natoli, Teresa Gamucci, Luigi Di Lauro, Maddalena Barba, Domenico Sergi, Claudio Botti, Andrea Michelotti, Luca Moscetti,[...]. Cancer Treat Rev 2015
Patrizia Vici, Laura Pizzuti, Clara Natoli, Teresa Gamucci, Luigi Di Lauro, Maddalena Barba, Domenico Sergi, Claudio Botti, Andrea Michelotti, Luca Moscetti,[...]. Cancer Treat Rev 2015
25
The potential of PARP inhibitors in genetic breast and ovarian cancers.
Yvette Drew, Hilary Calvert. Ann N Y Acad Sci 2008
Yvette Drew, Hilary Calvert. Ann N Y Acad Sci 2008
25
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
Soley Bayraktar, Angelica M Gutierrez-Barrera, Diane Liu, Tunc Tasbas, Ugur Akar, Jennifer K Litton, E Lin, Constance T Albarracin, Funda Meric-Bernstam, Ana M Gonzalez-Angulo,[...]. Breast Cancer Res Treat 2011
Soley Bayraktar, Angelica M Gutierrez-Barrera, Diane Liu, Tunc Tasbas, Ugur Akar, Jennifer K Litton, E Lin, Constance T Albarracin, Funda Meric-Bernstam, Ana M Gonzalez-Angulo,[...]. Breast Cancer Res Treat 2011
25
Updates in the treatment of basal/triple-negative breast cancer.
Mythili Shastry, Denise A Yardley. Curr Opin Obstet Gynecol 2013
Mythili Shastry, Denise A Yardley. Curr Opin Obstet Gynecol 2013
25
BRCA1/2 mutations and triple negative breast cancers.
Beth N Peshkin, Michelle L Alabek, Claudine Isaacs. Breast Dis 2010
Beth N Peshkin, Michelle L Alabek, Claudine Isaacs. Breast Dis 2010
25
Triple-negative breast cancer: role of specific chemotherapy agents.
Steven J Isakoff. Cancer J 2010
Steven J Isakoff. Cancer J 2010
25
Targeting triple-negative breast cancer: optimising therapeutic outcomes.
K Gelmon, R Dent, J R Mackey, K Laing, D McLeod, S Verma. Ann Oncol 2012
K Gelmon, R Dent, J R Mackey, K Laing, D McLeod, S Verma. Ann Oncol 2012
25
Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
Rachel Greenup, Adam Buchanan, Wendy Lorizio, Keelia Rhoads, Salina Chan, Tracey Leedom, Robin King, Jane McLennan, Beth Crawford, P Kelly Marcom,[...]. Ann Surg Oncol 2013
Rachel Greenup, Adam Buchanan, Wendy Lorizio, Keelia Rhoads, Salina Chan, Tracey Leedom, Robin King, Jane McLennan, Beth Crawford, P Kelly Marcom,[...]. Ann Surg Oncol 2013
25
Triple-negative breast cancer: new perspectives for targeted therapies.
Federica Tomao, Anselmo Papa, Eleonora Zaccarelli, Luigi Rossi, Davide Caruso, Marina Minozzi, Patrizia Vici, Luigi Frati, Silverio Tomao. Onco Targets Ther 2015
Federica Tomao, Anselmo Papa, Eleonora Zaccarelli, Luigi Rossi, Davide Caruso, Marina Minozzi, Patrizia Vici, Luigi Frati, Silverio Tomao. Onco Targets Ther 2015
25
Triple-negative breast cancer: novel therapies and new directions.
Sumanta Kumar Pal, Joanne Mortimer. Maturitas 2009
Sumanta Kumar Pal, Joanne Mortimer. Maturitas 2009
25
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement.
Alan Mackay, Britta Weigelt, Anita Grigoriadis, Bas Kreike, Rachael Natrajan, Roger A'Hern, David S P Tan, Mitch Dowsett, Alan Ashworth, Jorge S Reis-Filho. J Natl Cancer Inst 2011
Alan Mackay, Britta Weigelt, Anita Grigoriadis, Bas Kreike, Rachael Natrajan, Roger A'Hern, David S P Tan, Mitch Dowsett, Alan Ashworth, Jorge S Reis-Filho. J Natl Cancer Inst 2011
25
Subtyping of triple-negative breast cancer: implications for therapy.
Vandana G Abramson, Brian D Lehmann, Tarah J Ballinger, Jennifer A Pietenpol. Cancer 2015
Vandana G Abramson, Brian D Lehmann, Tarah J Ballinger, Jennifer A Pietenpol. Cancer 2015
25
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale.
Steven J Isakoff, Shannon Puhalla, Susan M Domchek, Michael Friedlander, Bella Kaufman, Mark Robson, Melinda L Telli, Véronique Diéras, Hyo Sook Han, Judy E Garber,[...]. Future Oncol 2017
Steven J Isakoff, Shannon Puhalla, Susan M Domchek, Michael Friedlander, Bella Kaufman, Mark Robson, Melinda L Telli, Véronique Diéras, Hyo Sook Han, Judy E Garber,[...]. Future Oncol 2017
25
Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.
Eunjung Lee, Roberta McKean-Cowdin, Huiyan Ma, Darcy V Spicer, David Van Den Berg, Leslie Bernstein, Giske Ursin. J Clin Oncol 2011
Eunjung Lee, Roberta McKean-Cowdin, Huiyan Ma, Darcy V Spicer, David Van Den Berg, Leslie Bernstein, Giske Ursin. J Clin Oncol 2011
25
Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
25
25
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.
Karen A Gelmon, Marc Tischkowitz, Helen Mackay, Kenneth Swenerton, André Robidoux, Katia Tonkin, Hal Hirte, David Huntsman, Mark Clemons, Blake Gilks,[...]. Lancet Oncol 2011
Karen A Gelmon, Marc Tischkowitz, Helen Mackay, Kenneth Swenerton, André Robidoux, Katia Tonkin, Hal Hirte, David Huntsman, Mark Clemons, Blake Gilks,[...]. Lancet Oncol 2011
25
Triple-negative breast cancer: present challenges and new perspectives.
Franca Podo, Lutgarde M C Buydens, Hadassa Degani, Riet Hilhorst, Edda Klipp, Ingrid S Gribbestad, Sabine Van Huffel, Hanneke W M van Laarhoven, Jan Luts, Daniel Monleon,[...]. Mol Oncol 2010
Franca Podo, Lutgarde M C Buydens, Hadassa Degani, Riet Hilhorst, Edda Klipp, Ingrid S Gribbestad, Sabine Van Huffel, Hanneke W M van Laarhoven, Jan Luts, Daniel Monleon,[...]. Mol Oncol 2010
25
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.
Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler,[...]. Lancet 2010
Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler,[...]. Lancet 2010
25
25
Triple-negative breast cancer: future prospects in diagnosis and management.
Shereef Elsamany, Sakher Abdullah. Med Oncol 2014
Shereef Elsamany, Sakher Abdullah. Med Oncol 2014
25
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer.
B Corkery, J Crown, M Clynes, N O'Donovan. Ann Oncol 2009
B Corkery, J Crown, M Clynes, N O'Donovan. Ann Oncol 2009
25
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
25
Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.
Bryan P Rowe, Peter M Glazer. Breast Cancer Res 2010
Bryan P Rowe, Peter M Glazer. Breast Cancer Res 2010
25
Treatment options for patients with triple-negative breast cancer.
Rafael Santana-Davila, Edith A Perez. J Hematol Oncol 2010
Rafael Santana-Davila, Edith A Perez. J Hematol Oncol 2010
25
An unexpected error occurred.
Please provide the following information to technical support:
Error Event: onRequest
Error details:
| struct | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cause |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Detail | An exception occurred while invoking an event handler method from Application.cfc. The method name is: onRequest. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Message | Event handler exception. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RootCause |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StackTrace | coldfusion.runtime.EventHandlerException: Event handler exception. at coldfusion.runtime.AppEventInvoker.onRequest(AppEventInvoker.java:319) at coldfusion.filter.ApplicationFilter.invoke(ApplicationFilter.java:551) at coldfusion.filter.RequestMonitorFilter.invoke(RequestMonitorFilter.java:43) at coldfusion.filter.MonitoringFilter.invoke(MonitoringFilter.java:40) at coldfusion.filter.PathFilter.invoke(PathFilter.java:162) at coldfusion.filter.IpFilter.invoke(IpFilter.java:45) at coldfusion.filter.ExceptionFilter.invoke(ExceptionFilter.java:96) at coldfusion.filter.ClientScopePersistenceFilter.invoke(ClientScopePersistenceFilter.java:28) at coldfusion.filter.BrowserFilter.invoke(BrowserFilter.java:38) at coldfusion.filter.NoCacheFilter.invoke(NoCacheFilter.java:60) at coldfusion.filter.GlobalsFilter.invoke(GlobalsFilter.java:38) at coldfusion.filter.DatasourceFilter.invoke(DatasourceFilter.java:22) at coldfusion.filter.CachingFilter.invoke(CachingFilter.java:62) at coldfusion.CfmServlet.service(CfmServlet.java:226) at coldfusion.bootstrap.BootstrapServlet.service(BootstrapServlet.java:311) at org.apache.catalina.core.ApplicationFilterChain.internalDoFilter(ApplicationFilterChain.java:228) at org.apache.catalina.core.ApplicationFilterChain.doFilter(ApplicationFilterChain.java:163) at coldfusion.monitor.event.MonitoringServletFilter.doFilter(MonitoringServletFilter.java:46) at coldfusion.bootstrap.BootstrapFilter.doFilter(BootstrapFilter.java:47) at org.apache.catalina.core.ApplicationFilterChain.internalDoFilter(ApplicationFilterChain.java:190) at org.apache.catalina.core.ApplicationFilterChain.doFilter(ApplicationFilterChain.java:163) at org.apache.tomcat.websocket.server.WsFilter.doFilter(WsFilter.java:53) at org.apache.catalina.core.ApplicationFilterChain.internalDoFilter(ApplicationFilterChain.java:190) at org.apache.catalina.core.ApplicationFilterChain.doFilter(ApplicationFilterChain.java:163) at org.apache.catalina.core.StandardWrapperValve.invoke(StandardWrapperValve.java:202) at org.apache.catalina.core.StandardContextValve.invoke(StandardContextValve.java:97) at org.apache.catalina.authenticator.AuthenticatorBase.invoke(AuthenticatorBase.java:542) at org.apache.catalina.core.StandardHostValve.invoke(StandardHostValve.java:143) at org.apache.catalina.valves.ErrorReportValve.invoke(ErrorReportValve.java:92) at org.apache.catalina.core.StandardEngineValve.invoke(StandardEngineValve.java:78) at org.apache.catalina.connector.CoyoteAdapter.service(CoyoteAdapter.java:373) at org.apache.coyote.ajp.AjpProcessor.service(AjpProcessor.java:462) at org.apache.coyote.AbstractProcessorLight.process(AbstractProcessorLight.java:65) at org.apache.coyote.AbstractProtocol$ConnectionHandler.process(AbstractProtocol.java:893) at org.apache.tomcat.util.net.NioEndpoint$SocketProcessor.doRun(NioEndpoint.java:1723) at org.apache.tomcat.util.net.SocketProcessorBase.run(SocketProcessorBase.java:49) at java.base/java.util.concurrent.ThreadPoolExecutor.runWorker(ThreadPoolExecutor.java:1128) at java.base/java.util.concurrent.ThreadPoolExecutor$Worker.run(ThreadPoolExecutor.java:628) at org.apache.tomcat.util.threads.TaskThread$WrappingRunnable.run(TaskThread.java:61) at java.base/java.lang.Thread.run(Thread.java:834) Caused by: coldfusion.runtime.UDFMethod$InvalidArgumentTypeException: The COCITEDARTICLECITATION_COUNT argument passed to the calculArticleSimilarity function is not of type numeric. at coldfusion.runtime.UDFMethod._validateArgWithValidator(UDFMethod.java:1434) at coldfusion.runtime.UDFMethod._validateRequiredArg(UDFMethod.java:1400) at cfpubmed2ecfc1897273376$funcCALCULARTICLESIMILARITY.runFunction(C:\home\cocites.com\wwwroot\cfc\pubmed.cfc:215) at coldfusion.runtime.UDFMethod.invoke(UDFMethod.java:554) at coldfusion.runtime.UDFMethod$ReturnTypeFilter.invoke(UDFMethod.java:485) at coldfusion.runtime.UDFMethod$ArgumentCollectionFilter.invoke(UDFMethod.java:448) at coldfusion.filter.FunctionAccessFilter.invoke(FunctionAccessFilter.java:95) at coldfusion.runtime.UDFMethod.runFilterChain(UDFMethod.java:399) at coldfusion.runtime.UDFMethod.runFilterChain(UDFMethod.java:372) at coldfusion.runtime.UDFMethod.invoke(UDFMethod.java:288) at coldfusion.runtime.TemplateProxy.invoke(TemplateProxy.java:830) at coldfusion.runtime.TemplateProxy.invoke(TemplateProxy.java:613) at coldfusion.runtime.TemplateProxy.invoke(TemplateProxy.java:438) at coldfusion.runtime.CfJspPage._invoke(CfJspPage.java:3627) at coldfusion.runtime.CfJspPage._invoke(CfJspPage.java:3604) at cfcoCitedArticles2ecfm1072712._factor11(C:\home\cocites.com\wwwroot\coCitedArticles.cfm:483) at cfcoCitedArticles2ecfm1072712._factor14(C:\home\cocites.com\wwwroot\coCitedArticles.cfm:401) at cfcoCitedArticles2ecfm1072712._factor15(C:\home\cocites.com\wwwroot\coCitedArticles.cfm:321) at cfcoCitedArticles2ecfm1072712._factor17(C:\home\cocites.com\wwwroot\coCitedArticles.cfm:298) at cfcoCitedArticles2ecfm1072712.runPage(C:\home\cocites.com\wwwroot\coCitedArticles.cfm:1) at coldfusion.runtime.CfJspPage.invoke(CfJspPage.java:262) at coldfusion.tagext.lang.IncludeTag.handlePageInvoke(IncludeTag.java:735) at coldfusion.tagext.lang.IncludeTag.doStartTag(IncludeTag.java:565) at coldfusion.runtime.CfJspPage._emptyTcfTag(CfJspPage.java:4329) at cfApplication2ecfc1402755519$funcONREQUEST.runFunction(C:\home\cocites.com\wwwroot\Application.cfc:182) at coldfusion.runtime.UDFMethod.invoke(UDFMethod.java:554) at coldfusion.runtime.UDFMethod$ReturnTypeFilter.invoke(UDFMethod.java:485) at coldfusion.runtime.UDFMethod$ArgumentCollectionFilter.invoke(UDFMethod.java:448) at coldfusion.filter.FunctionAccessFilter.invoke(FunctionAccessFilter.java:95) at coldfusion.runtime.UDFMethod.runFilterChain(UDFMethod.java:399) at coldfusion.runtime.UDFMethod.runFilterChain(UDFMethod.java:372) at coldfusion.runtime.UDFMethod.invoke(UDFMethod.java:288) at coldfusion.runtime.TemplateProxy.invoke(TemplateProxy.java:830) at coldfusion.runtime.TemplateProxy.invoke(TemplateProxy.java:613) at coldfusion.runtime.TemplateProxy.invoke(TemplateProxy.java:438) at coldfusion.runtime.AppEventInvoker.invoke(AppEventInvoker.java:115) at coldfusion.runtime.AppEventInvoker.onRequest(AppEventInvoker.java:308) ... 39 more | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Suppressed |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TagContext |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Type | Application | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| name | onRequest | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||